{"nct_id":"NCT03099135","title":"A Long Term Follow-up Study in Participants Treated in a Preceding Phase 2 or 3 Study With a Regimen Containing Odalasvir and AL-335 With or Without Simeprevir for the Treatment of Hepatitis C Virus (HCV) Infection","status":"TERMINATED","status_verified_date":"2025-01","start_date":"2017-04-10","start_date_type":"ACTUAL","primary_completion_date":"2018-02-01","primary_completion_date_type":"ACTUAL","completion_date":"2018-02-13","completion_date_type":"ACTUAL","phases":["PHASE3"],"tickers":["JNJ"]}